Latest Insider Transactions at Mi Nk Therapeutics, Inc. (INKT)
This section provides a real-time view of insider transactions for Mi Nk Therapeutics, Inc. (INKT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MiNK Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MiNK Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 03
2024
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
18,295
+12.88%
|
$0
$0.82 P/Share
|
Sep 03
2024
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
18,753
+14.65%
|
$0
$0.82 P/Share
|
Sep 03
2024
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
21,649
+14.65%
|
$0
$0.82 P/Share
|
Sep 03
2024
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+5.1%
|
$0
$0.82 P/Share
|
Jun 03
2024
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
15,077
+12.51%
|
$0
$0.99 P/Share
|
Jun 03
2024
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
17,841
+14.59%
|
$0
$0.99 P/Share
|
Jun 03
2024
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
15,454
+14.59%
|
$0
$0.99 P/Share
|
Jun 03
2024
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
17,967
+4.48%
|
$0
$0.99 P/Share
|
Mar 01
2024
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
18,816
+4.9%
|
$0
$0.95 P/Share
|
Mar 01
2024
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
15,790
+14.88%
|
$0
$0.95 P/Share
|
Mar 01
2024
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
18,685
+17.74%
|
$0
$0.95 P/Share
|
Mar 01
2024
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
16,185
+17.74%
|
$0
$0.95 P/Share
|
Dec 01
2023
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
17,068
+20.08%
|
$17,068
$1.04 P/Share
|
Dec 01
2023
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
14,784
+20.08%
|
$14,784
$1.04 P/Share
|
Dec 01
2023
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
14,424
+16.21%
|
$14,424
$1.04 P/Share
|
Dec 01
2023
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
17,188
+4.72%
|
$17,188
$1.04 P/Share
|
Oct 16
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
429
+0.0%
|
$429
$1.1 P/Share
|
Oct 13
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
19,373
+0.09%
|
$19,373
$1.1 P/Share
|
Oct 12
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
3,173
+0.01%
|
$3,173
$1.1 P/Share
|
Oct 11
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
695,750
-74.98%
|
-
|
Oct 04
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
15,001
+0.07%
|
$15,001
$1.09 P/Share
|
Oct 03
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
65,000
-6.55%
|
$0
$0.94 P/Share
|
Oct 02
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
58,550
-5.57%
|
$58,550
$1.04 P/Share
|
Sep 29
2023
|
Jennifer Buell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,000
-2.32%
|
$25,000
$1.15 P/Share
|
Sep 27
2023
|
Jennifer Buell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
695,750
+39.26%
|
-
|
Sep 01
2023
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
9,590
+13.76%
|
$9,590
$1.46 P/Share
|
Sep 01
2023
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
12,158
+19.29%
|
$12,158
$1.46 P/Share
|
Sep 01
2023
|
John Baldoni |
BUY
Grant, award, or other acquisition
|
Direct |
9,846
+19.29%
|
$9,846
$1.46 P/Share
|
Sep 01
2023
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
12,244
+3.58%
|
$12,244
$1.46 P/Share
|
Sep 01
2023
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
10,531
+19.29%
|
$10,531
$1.46 P/Share
|
Aug 29
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
29,678
+0.14%
|
$29,678
$1.52 P/Share
|
Aug 28
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
12,808
+0.06%
|
$12,808
$1.45 P/Share
|
Aug 24
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
170,244
+0.78%
|
$170,244
$1.54 P/Share
|
Jun 01
2023
|
John Baldoni |
BUY
Grant, award, or other acquisition
|
Direct |
8,168
+20.58%
|
$8,168
$1.76 P/Share
|
Jun 01
2023
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
7,955
+13.56%
|
$7,955
$1.76 P/Share
|
Jun 01
2023
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
8,736
+20.58%
|
$8,736
$1.76 P/Share
|
Jun 01
2023
|
Barbara Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
10,086
+20.58%
|
$10,086
$1.76 P/Share
|
Jun 01
2023
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
10,157
+3.1%
|
$10,157
$1.76 P/Share
|
May 11
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
23,361
+0.11%
|
$23,361
$1.43 P/Share
|
May 10
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
22,065
+0.1%
|
$22,065
$1.51 P/Share
|
May 05
2023
|
Garo H Armen |
SELL
Open market or private sale
|
Direct |
100,000
-5.09%
|
$0
$0.95 P/Share
|
May 05
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
100,200
+0.23%
|
$100,200
$1.1 P/Share
|
May 04
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
21,473
+0.1%
|
$21,473
$1.22 P/Share
|
May 03
2023
|
Agenus Inc |
BUY
Open market or private purchase
|
Direct |
128,689
+0.6%
|
$128,689
$1.08 P/Share
|
May 02
2023
|
Garo H Armen |
BUY
Open market or private purchase
|
Direct |
100,000
+4.81%
|
$0
$0.95 P/Share
|
May 01
2023
|
Agenus Inc |
SELL
Other acquisition or disposition
|
Direct |
4,988,273
-18.94%
|
-
|
Mar 01
2023
|
Ulf Wiinberg |
BUY
Grant, award, or other acquisition
|
Direct |
6,699
+13.55%
|
$13,398
$2.09 P/Share
|
Mar 01
2023
|
Brian Corvese |
BUY
Grant, award, or other acquisition
|
Direct |
8,553
+2.71%
|
$17,106
$2.09 P/Share
|
Mar 01
2023
|
John Baldoni |
BUY
Grant, award, or other acquisition
|
Direct |
6,878
+22.75%
|
$13,756
$2.09 P/Share
|
Mar 01
2023
|
Peter Behner |
BUY
Grant, award, or other acquisition
|
Direct |
7,357
+22.75%
|
$14,714
$2.09 P/Share
|